URGN — UroGen Pharma Ltd.
6 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about URGN (2026-11-04)
- UroGen Pharma reported Q3 2026 financial results, including $68.0 million in ZUSDURI revenue.
- The company reported a Q3 2026 EPS of -$0.03, missing the $0.09 estimate, with revenue of $89.0 million.
- UroGen announced it will present at the Guggenheim conference in Boston on November 10.
| Bluesky | 4 | community |
| GDELT | 1 | news |
| SEC EDGAR 8-K | 1 | filings |